Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates

• click to rate

  Posted by Two Blokes May 15 - Filed in Stock - 1 view
  
  - Topline results from pivotal Phase 3 INDIGO trial in Immunoglobulin G4-Related Disease expected around year-end 2025 -